Cargando…
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement?
Fabry disease is an X-linked lysosomal storage disease caused by mutations in the GLA gene that lead to a reduction or an absence of the enzyme α-galactosidase A, resulting in the progressive and multisystemic accumulation of globotriaosylceramide. Clinical manifestation varies from mild to severe,...
Autores principales: | Ravarotto, Verdiana, Simioni, Francesca, Carraro, Gianni, Bertoldi, Giovanni, Pagnin, Elisa, Calò, Lorenzo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262438/ https://www.ncbi.nlm.nih.gov/pubmed/30400144 http://dx.doi.org/10.3390/jcm7110409 |
Ejemplares similares
-
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?
por: Ravarotto, Verdiana, et al.
Publicado: (2018) -
The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease
por: Ravarotto, Verdiana, et al.
Publicado: (2021) -
The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study
por: Bertoldi, Giovanni, et al.
Publicado: (2022) -
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients
por: Calò, Lorenzo A., et al.
Publicado: (2020) -
Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies
por: Ravarotto, Verdiana, et al.
Publicado: (2022)